We've invested over 2 million dollars in preeclampsia research
September 2023 - The 2023 Peter Joseph Pappas Research Grant application cycle is now closed.
Submitted Letters of Intent that are of interest to the scientific review committee and the Preeclampsia Foundation’s Board of Directors will then be invited to submit full applications by Monday, October 9, 2023, with award decisions rendered in December 2023.
Named for the infant son of preeclampsia survivor Lauren Pappas and her husband Clement, the program seeks to award multiple grants totaling up to $200,000 each year. The ultimate goal of this grant program is to drive research that will eliminate the delivery of pre-term babies as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy.
Read more about the Peter Joseph Pappas Research Grant Program.
Questions? Contact PJPGrants@preeclampsia.org
PREVIOUS PETER JOSEPH PAPPAS GRANT RECIPIENTS
September 2023 - The 2023 Vision Grant application phase is now closed.
The Preeclampsia Foundation's affiliate organization Preeclampsia Foundation Canada have awarded two medical research Vision Grants to study preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy, up to $25,000 CAD.
Vision Grants are intended to provide initial funding for novel, innovative research by promising young investigators that will advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. Post-doctoral, Clinical Fellows, or Early Stage Investigators only are eligible to apply. Projects with potential to alter clinical management and improve patient outcomes will receive priority, but any well-considered research proposal will be accepted for review. International applications are welcome; however, submissions must be in English. The Foundation has committed to funding grants that address known research knowledge gaps.
The next grant cycle will be announced in Q1 2024.
Questions? Contact VisionGrants@preeclampsia.org
PREVIOUS VISION GRANT RECIPIENTS
Please note: The EMPOWER program is not currently being funded. No applications are being accepted at this time.
EMPOWER (EMpowering Progress in Obstetric and Women's hEalth Research) was established to create partnerships between mentors and single sites or groups within low- and middle-income countries to improve clinical and health services research into the hypertensive disorders of pregnancy.
When available, funding is for a two-year research project. The immediate objective is the completion of a project designed by a local investigator and, when appropriate, the dissemination of the results of the study to change practices and improve care.
EMPOWER is a collaboration of the International Society for the Study of Hypertension in Pregnancy, the Preeclampsia Foundation, PRE-EMPT/Global Pregnancy Collaboration, and supporting organization New Zealand Action on Pre-eclampsia.
PREVIOUS EMPOWER GRANT RECIPIENTS
Questions? Contact empower@preeclampsia.org
Please contact our Research Manager if you would like the Preeclampsia Foundation to help you recruit participants for a research study or focus group, or have any questions about the Preeclampsia Registry.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
Preeclampsia Foundation Canada has announced that Kylie Belchamber, PhD of University of Birmingham, and Serena Gundy, MD, FRCP of McMaster University, are their 2023 Vision Grant research award recip...
Amit Zeisel, PhD and Ido Solt, MD and their research team at the Technion – Israel Institute of Technology and Rambam Hospital, together with Prof. Simcha Yagel, MD of Hadassa Hospital, have pub...
Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials Finding strategies for preventing preeclampsia is a top priority in...
Masked Pregnancy-Associated Hypertension as a Predictor of Adverse Outcomes Pregnant women who have risk factors for preeclampsia may be advised by their health care provider to monitor their...
Preeclampsia Prevention by Timed Birth at Term In this study, researchers looked at different ways to find out if a pregnant woman might get preeclampsia at term (>37 weeks) and when would be...